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Introduction
The optimal treatment for severe coronary artery disease remains 
coronary artery bypass grafting (CABG).1 Differences in the pat-
ency rates of various vascular conduits including internal mam-
mary artery (IMA) and saphenous vein (SV) and the resulting 
difference in patient survival when differing grafting strategies 
are utilized have long been recognized.2-4 The specific factors 
which govern this discrepancy are not fully understood; how-
ever, the risk factors for ischaemic heart disease are believed to 
contribute (Fig. 1).5,6 The endothelium has long been known to 
play a pivotal role in the regulation of vascular tone and homeo-
stasis,7 producing a wide array of vasoactive compounds. The 
ability of the conduits to adapt to oxidative stress associated with 
the excessive bioavailability of reactive oxygen species (ROS) is 
also believed to be important.8-12 The interaction between risk 
factor status and abnormal levels of ROS is at best complex, with 
17-β-estradiol eliciting vasodilatation,13 and diabetes having 
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no effect on endothelial responses in some studies14 although 
changes have been demonstrated in the levels of superoxide 
(O2
.-) produced by diabetic subjects. Smoking has been shown to 
reduce levels of nitric oxide (NO), but this was associated with 
increased production of nitric oxide synthase.15 Manipulation of 
H2O2 levels has been shown to produce opposite effects at differ-
ing concentration by the same group.16,17
Vascular reactivity has long been utilized as a marker of 
endothelial function,18,19 and this concept underpins our inves-
tigation methodology. Using isometric tension studies in human 
vascular samples, we sought to investigate the two commonly 
used CABG conduits. Our aim was to delineate if there was a 
correlation between the type and presence of risk factors and 
endothelial responses in these conduits.
Endothelium-dependent vasomotion is generally accepted 
as being reflective of the overall function of the endothelium,20 
and is considered to be an early marker of atherosclerosis.21   
A direct link between vascular responses to acetylcholine and 
The aim of this study was to investigate if there was a link between the relaxant responses in saphenous vein (sV) and 
internal mammary artery (IMa) segments obtained from patients undergoing coronary artery bypass grafting and 
the patients’ cardiovascular risk factors. endothelium-(in)dependent relaxations were assessed by isometric tension 
studies. endothelium-dependent relaxant responses were greater in IMa than sV and gender, smoking profile and 
history of hypertension but not diabetes appeared to have an influence on these responses. endothelium-dependent 
relaxant responses in both IMa and sV were greater in males than females and relaxant responses in IMa segments 
were attenuated in smokers, whereas the opposite effect was noted in sV segments. endothelium-dependent relaxant 
responses in sV were lower in patients with hypertension. endothelium-independent relaxant responses were greater in 
IMa than sV. endothelium-independent responses were greater in male patients’ sV segments, but gender played no role 
in IMa segments. Diabetes had no effect on endothelium-independent responses in IMa, but sV segments from diabetic 
patients had greater responses. Neither conduit’s endothelium-independent response was affected by hypertensive 
status. The relationship between risk factor status and endothelial responses is multifactorial, with gender, hypertension, 
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directly affects the vascular smooth muscle, irrespective of 
whether the endothelium is functional,23 and it was used to elicit 
vascular responses independent of the endothelium.
Results
Patient characteristics. Of the 126 patients, 103 were male,   
33 had diabetes mellitus and 67 were hypertensive, with 24 current 
and 62 ex-smokers. There was no significant difference between the 
ages of male (median 66y) and female (median 68y) patients (Table 
1). These patients contributed a total of 449 vascular segments (212 
IMA).
Conduit influence. Endothelium-dependent relaxant res-
ponses were greater in IMA than SV with maximal responses 
being 53.12 ± 2.13% and 35.47 ± 2.13%, respectively (p < 0.05, 
Fig. 2A). Similarly, endothelium-independent relaxant responses 
were greater in IMA (117.30 ± 1.64% versus 101.86 ± 1.56%,   
p < 0.05, Fig. 2B). Contractions to high potassium solution were 
significantly greater with IMA than SV (938.3 ± 42.4 g versus 724.7 
± 38.7 g per g dry tissue, n ≥ 50, p < 0.05).
Risk factor influence. Endothelium-dependent relaxant 
responses were significantly better in male compared to female 
patients with both IMA and SV (p < 0.05, Fig. 3A), whilst the 
endothelium-independent relaxant responses were significantly bet-
ter in SV segments from male patients (p < 0.05) but not IMA seg-
ments (p > 0.05, Fig. 3B).
Of the 126 patients included for analysis, 125 were on lipid 
modifying medication (119 were on a statin), so meaningful analy-
sis in relation to this risk factor was not possible. With both con-
duits, there were no differences in endothelium-dependent relaxant 
responses between diabetic and non-diabetic patients (IMA, 
p > 0.05; SV, p > 0.05, Fig. 4A). In SV segments, however, the 
long term outlook had been demonstrated,22 therefore we chose 
acetylcholine to interrogate vascular responses dependent upon 
the endothelium. Sodium nitroprusside is a NO donor which 
Table 1. Breakdown of risk factors and medications by gender
Characteristics Male Female
Age 29–82 y 44–79 y
Total numbers 103 23
Vascular Risk Factors
Current smoker 21 3
ex-smoker 55 7
Non-smoker 27 13
Diabetic 30 3
Non-diabetic 73 20
hypertensive 54 13
Non-hypertensive 49 10
Drug therapy
anti-platelet 102 23
statin 97 22
Beta-Blocker 88 19
aCe-Inhibitor 79 16
Calcium Channel Blocker 23 6 
potassium Channel activator 50 11
Nitrate 49 13
Diuretic 32 6
Demographic breakdown and distribution of pre-operative 
  medications for included patients. aCe-inhibitor; angiotensin 
  converting enzyme inhibitor.
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(p < 0.05). Responses in current versus non-smokers are seen in 
Figure 6A (endothelium-dependent: both IMA and SV p < 0.05) 
and 6B (endothelium-independent: both IMA and SV p > 0.05). 
Responses in current versus ex-smokers are seen in Figure 7A 
(endothelium-dependent: IMA p < 0.05) and 7B (endothelium-
independent: IMA p > 0.05, SV p < 0.05).
There were no significant differences in the contractile function 
of each conduit with respect to each risk factor. For example, with 
IMA segments, hypertensives gave 917.7 ± 486.1 g versus 968.8 
± 474.4 g per g of dry conduit. With SV segments, diabetics gave 
640.6 ± 293.3 g versus 749.2 ± 434.3 g per g of dry conduit.
Discussion
This study explicitly demonstrates that both the endothelium-
dependent and independent relaxant responses of IMA segments 
endothelium-independent relaxant responses of diabetic patients 
were significantly better than the responses of non-diabetic patients 
(p < 0.05, Fig. 4B).
In hypertensive patients, although no significant differences were 
observed in IMA endothelium-dependent relaxant responses, reduced 
relaxation was noted in SV specifically with the highest concentra-
tion of acetylcholine (p < 0.05, Fig. 5A). With both conduits, there 
were no differences in endothelium-independent relaxant responses 
between hypertensive and non-hypertensive patients (Fig. 5B).
The relationship between smoking history and relaxant 
responses is complex. In IMA segments, current smokers have 
the worst endothelium-dependent responses, ex-smokers next 
and non-smokers the best (p < 0.05). The opposite is true for 
SV segments, with non-smokers having the worst endothelium-
dependent responses, ex-smokers next and current smokers the 
best (p < 0.05). In IMA segments, there were no differences in the 
endothelium-independent relaxant responses (p > 0.05), however, 
in SV segments, ex-smokers have the worst endothelium-indepen-
dent responses, non-smokers next and current smokers the best 
Figure 2. endothelium-dependent (a) and -independent (B) relaxant 
responses are significantly greater in both internal mammary arter-
ies (IMa; p < 0.05, n = 89) and saphenous veins (sV; p < 0.05, n = 92). 
Vessel segments are pre-contracted to a plateau using a sub-maximal 
dose of phenylephrine, then exposed to increasing concentrations of 
an endothelium-dependent (acetylcholine) or -independent (sodium 
nitroprusside) relaxant. Comparisons are made using paired repeated 
measures 2-way aNOVa and individual dose points are compared using 
Bonferroni post-hoc testing, with the indicated doses being signifi-
cantly different from one another (p < 0.05). Results are expressed as 
mean ± seM.
Figure 3. endothelium-dependent relaxant responses (a) in internal 
mammary artery (IMa) and saphenous vein (sV) with male (n = 103) 
versus female (n = 23) patients, and endothelium-independent relax-
ant responses (B) in IMa and sV with male (n = 65) versus female (n = 
11) patients are displayed. Vessel segments are pre-contracted to a 
plateau using a sub-maximal dose of phenylephrine, then exposed to 
increasing concentrations of an endothelium-dependent (acetylcho-
line) or -independent (sodium nitroprusside) relaxant. Comparisons are 
made using unpaired repeated measures 2-way aNOVa and individual 
dose points are compared using Bonferroni post-hoc testing, with the 
indicated doses being significantly different from one another (p < 0.05, 
compared to the other sex). Differences in individual data points with 
IMa segments are noted below the curves, whilst differences with sV 
segments are indicated above the curves. Both IMa and sV endothe-
lium-dependent relaxant responses are significantly better in male 
compared to female patients (p < 0.05, a). endothelium-independent 
relaxant responses of sV are significantly better in male versus female 
patients (p < 0.05, B) whilst no significant differences are observed with 
IMa segments. Results are expressed as mean ± seM.202  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 3
when compared to their male counterparts. With IMA segments, 
there was a difference in endothelium-dependent relaxant responses 
but no difference in endothelium-independent relaxant responses. 
Together, these data reveal that the gender difference between con-
duits is due solely to the endothelium with IMA segments, but both 
endothelium and smooth muscle levels for SV segments. These data 
uncover a further mechanism that may explain the poorer outcomes 
of CABG in female patients.
We have demonstrated that hypertension has no effect on 
endothelium-dependent responses in IMA. This lack of effect in 
IMA has been demonstrated before,29 however other authors have 
noted decreased endothelial responses in the presence of hyperten-
sion.30 There are few available vascular reactivity data to which we 
can compare our SV results, with many authors31-35 concentrating 
upon particular facets of SV response utilising specific chemicals. 
Although not looking specifically at hypertension per se, Al-Benna 
and colleagues demonstrated reduced endothelial responses in SV 
obtained from coronary artery disease patients compared with 
Figure 5. endothelium-dependent relaxant responses (a) in internal 
mammary artery (IMa) and saphenous vein (sV) with hypertensive 
(n = 67) versus non-hypertensive (n = 59) patients, and endothelium-
independent relaxant responses (B) in IMa and sV with hypertensive 
(n = 40) versus non-hypertensive (n = 34) patients are displayed. Vessel 
segments are pre-contracted to a plateau using a sub-maximal dose 
of phenylephrine, then exposed to increasing concentrations of an 
endothelium-dependent (acetylcholine) or -independent (sodium  
nitroprusside) relaxant. Comparisons are made using unpaired repeat-
ed measures 2-way aNOVa and individual dose points are compared 
using Bonferroni post-hoc testing, with the indicated doses being 
significantly different from one another (p < 0.05, compared to the 
other group). The individual data point difference with sV segments is 
noted above the curve (a). endothelium-dependent relaxant responses 
of sV are significantly better in non-hypertensive versus hypertensive 
patients (p < 0.05, a) whilst no significant differences are observed with 
IMa segments. There are no significant differences in endothelium-
independent relaxant responses with either conduit (both p > 0.05, B). 
Results are expressed as mean ± seM.
are greater than the relaxant responses of SV segments. This is 
widely described in the literature8,12 and merely serves as the start-
point for investigating which particular mechanisms are responsible 
for this response.
Gender has been shown to be an independent risk factor for 
long term adverse outcomes following CABG,24 with female 
patients being older and having a greater incidence of risk fac-
tors. Women have a lower incidence of coronary artery disease 
than men of comparable age, with oestrogen seemingly being the 
protective agent.13,25 For a woman to develop coronary disease of 
adequate severity to require CABG, it is likely that she has to have a 
greater risk factor burden than a man of comparable age. Enhanced 
endothelium-dependent relaxant responses in male as compared 
to female subjects has been previously reported,26,27 but is not uni-
versal,28 however, no studies are available comparing endothelium-
independent relaxant responses in male versus female patients. We 
have demonstrated that both endothelium-dependent and -inde-
pendent relaxant responses are worse in female patients’ SV samples 
Figure 4. endothelium-dependent relaxant responses (a) in internal 
mammary artery (IMa) and saphenous vein (sV) with diabetic (n = 33) 
versus non-diabetic (n = 93) patients, and endothelium-independent 
relaxant responses (B) in IMa and sV with diabetic (n = 20) versus non-
diabetic (n = 55) patients are displayed. Vessel segments are pre- 
contracted to a plateau using a sub-maximal dose of phenylephrine, 
then exposed to increasing concentrations of an endothelium-depen-
dent (acetylcholine) or -independent (sodium nitroprusside) relaxant. 
Comparisons are made using unpaired repeated measures 2-way 
aNOVa and individual dose points are compared using Bonferroni post-
hoc testing, with the indicated doses being significantly different from 
one another (p < 0.05, compared to the other group). The individual 
data point difference with sV segments is noted above the curve (B). 
There are no significant differences in endothelium-dependent relaxant 
responses with either conduit (both p > 0.05, a). endothelium-indepen-
dent relaxant responses of sV are significantly better in diabetic versus 
non-diabetic patients (p < 0.05, B) whilst no significant differences are 
observed with IMa segments. Results are expressed as mean ± seM.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  203
There are worsened endothelium-independent responses with non-
diabetic as compared to diabetic patients. This effect has not been 
demonstrated before, the typical data in the literature showing no 
differences in responses.14 We have demonstrated that a given risk 
factor per se may have a unique effect on vascular relaxation by 
impairing mechanisms at either endothelial or vascular smooth 
muscle cell level or a combination of both.
The effect smoking status has on the endothelial responses of 
the IMA was as expected from the literature, with a reduction in 
response with increased exposure to inhaled tobacco smoke, and in 
line with what is seen in the post-operative phase.41 The endothe-
lial responses in SV segments were contrary to that expected, and 
at odds with the behaviour of SV bypass grafts in the post-CABG 
phase.42,43 There are few data available concerning endothelium-
independent conduit responses to smoking, and that data which 
does exist is contradictory.44,45 Clearly there is a more complex rela-
tionship between smoking status and vascular function than simple 
direct injury. A possible explanation is that there is upregulation 
control subjects.36 The demographic data from their paper shows 
that the groups were similar except for hypertension and cholesterol 
level. Therefore, one can conclude that the differences between the 
control and study patients’ SV endothelial responses may be in part 
due to hypertension and hypercholesterolaemia. Hypertension is 
associated with increased oxidative stress, caused by either increased 
activity of oxidant enzymes, and/or dysfunction of anti-oxidant 
enzymes.37,38
There are no differences in endothelium-dependent relaxant 
responses due to presence of diabetes in either conduit despite the 
extensive array of potential mechanisms affected, such as a reduc-
tion in NO production, overproduction of ROS, reduced levels of 
antioxidants, increased protein glycosylation and enhanced glucose 
auto-oxidation.7 These data are at odds with some authors,5,39 but 
in agreement with others.14 The data pertaining to endothelial 
(dys)function in diabetic subjects is contradictory, with increased, 
unchanged and even reduced levels of NO being reported.7,40 
Figure 7. endothelium-dependent relaxant responses (a) in internal 
mammary artery (IMa) and saphenous vein (sV) with current (n = 24) 
versus ex-smokers (n = 62). endothelium-independent relaxant respons-
es (B) in IMa and sV with current (n = 16) versus ex-smokers (n = 35) are 
displayed. Vessel segments are pre-contracted to a plateau using a sub-
maximal dose of phenylephrine, then exposed to increasing concentra-
tions of an endothelium-dependent (acetylcholine) or -independent 
(sodium nitroprusside) relaxant. Comparisons are made using unpaired 
repeated measures 2-way aNOVa, and individual dose points are com-
pared using Bonferroni post-hoc testing, with the indicated doses being 
significantly different from one another (p < 0.05, compared to the 
other group). The individual data point differences with sV segments 
are noted above the curve (B). The endothelium-dependent relaxant 
responses in IMa segments of ex-smokers are significantly better than 
those of their smoking counterparts (p < 0.05, a) with no individual 
dose reaching significance, whilst there are no differences between the 
responses in sV segments (p > 0.05). There are no significant differences 
in endothelium-independent relaxant responses in IMa segments (p > 
0.05), however the endothelium-independent relaxant responses in sV 
segments of current smokers were better than their ex-smoking coun-
terparts (p < 0.05, B). Results are expressed as mean ± seM.
Figure 6. endothelium-dependent relaxant responses (a) in internal 
mammary artery (IMa) and saphenous vein (sV) with current (n = 24) 
versus non-smokers (n = 40), and endothelium-independent relaxant 
responses (B) in IMa and sV with current (n = 16) versus non-smokers 
(n = 22) are displayed. Vessel segments are pre-contracted to a plateau 
using a sub-maximal dose of phenylephrine, then exposed to increas-
ing concentrations of an endothelium-dependent (acetylcholine) or 
-independent (sodium nitroprusside) relaxant. Comparisons are made 
using unpaired repeated measures 2-way aNOVa and individual dose 
points are compared using Bonferroni post-hoc testing, with the indi-
cated doses being significantly different from one another (p < 0.05, 
compared to the other group). Differences in individual data points 
with IMa segments are noted below the curves, whilst differences 
with sV segments are indicated above the curves. The endothelium-
dependent relaxant responses in IMa segments of non-smokers are 
significantly better than those of their smoking counterparts (p < 0.05), 
whilst the responses in sV segments of current smokers are better than 
those of non-smokers (p < 0.05, a). endothelium-independent relaxant 
responses of sV are significantly better in current smokers versus non-
smokers (p < 0.05, B) whilst no significant differences are observed with 
IMa segments. Results are expressed as mean ± seM.204  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 3
as a fasting plasma glucose level greater than 7 mmol/l or 11.1 
mmol/l following a glucose load (tolerance test); smoking his-
tory with current smoking being defined as having consumed 
inhaled tobacco smoke within 3 months of operation; and 
hypercholesterolaemia, with the cut-off point being defined as 
a total cholesterol ≥5.2 mmol/l.
Vascular reactivity. Vascular samples were dissected free of 
their surrounding tissues in an atraumatic fashion and sharply 
divided into 2–3 mm rings. Following calibration of the data 
acquisition system, these rings were individually mounted 
between triangular stirrups from isometric force transducers in 
an 8-bath organ chamber system under physiological condi-
tions in Krebs buffer solution containing (all in mmol/l): NaCl 
118.3, KCl 4.7, MgSO4 1.2, KH2PO4 1.2, CaCl 2.5, NaHCO3 
25, Glucose 11.1, pH 7.4, at 37°C. The solution was gassed 
with a 95% O2, 5% CO2 mix. Data were captured from these 
transducers via an 8-channel data acquisition system (ML780), 
and recorded in Chart v4 (ADinstruments Ltd., UK). After 
mounting, the vascular rings were allowed to equilibrate under 
tension for 90 minutes, with IMA segments being placed under 
2.5 g of tension and SV segments under 1.5 g of tension.
The first process was to produce a contraction-concentra-
tion curve. The vessels were contracted with phenylephrine 
(0.001 to 30 µmol/l). Following a washout period, where the 
vessels returned to baseline tension, a sub-maximal dose was 
administered, to produce a plateau of contraction. From this 
plateau of contraction, ten acetylcholine doses (0.001 to 30 
µmol/l) were added in a stepwise fashion, eliciting endothe-
lium-dependent relaxant responses. This reagent was used to 
interrogate risk-factor influence in line with its wide utilisation 
within the literature. A second washout period then followed. 
Next, the process was repeated with sodium nitroprusside to 
demonstrate the contribution direct stimulation of the vascular 
smooth muscle cells has in these different conduits, with poten-
tially different populations of smooth muscle cells. Eight step-
wise doses (0.001 to 3 µmol/l) of this commonly used reagent 
within the vascular reactivity field assessed endothelium-inde-
pendent relaxant responses. Following a final washout period, 
the vascular rings were subjected to a high potassium concen-
tration (120 mmol/l) to directly stimulate the smooth muscle, 
bypassing all pathways, and confirming viability of the sample. 
The rings were air-dried overnight, and then weighed to index 
their contractions.
Statistical analysis. Analysis of relaxant responses was 
undertaken using repeated measures two-way ANOVA in all 
cases, with risk factor comparisons being unpaired. The relax-
ant responses analyses were performed using Prism v4 for 
Windows (GraphPad Software, San Diego, CA).
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